BASH Guideline

Abisaab, J., Nevadunsky, N., & Flomenbaum, N. (2004). Emergency department presentation of bilateral carotid artery dissections in a postpartum patient. Ann Emerg Med, 44(5), 484-489.

Acute treatment of migraine attacks, e., safety of a nonsteroidal anti-inflammatory, d., diclofenac, p., in comparison to oral, s., & placebo. (1999). The Diclofenac- K/Sumatriptan Migraine Study Group. Cephalalgia, 19(4), 232-240.

Agostoni, E. (2004). Headache in cerebral venous thrombosis. Neurol Sci, S206-210. https://doi.org/10.1007/s10072-004-0287-3

Ahrens, S. P., Farmer, M. V., & Williams, D. L. (1999). Efficacy and safety of rizatriptan wafer for the acute treatment of migraine. Rizatriptan Wafer Protocol 049 Study Group, 19(5), 525-530.

Ailani, J., Lipton, R. B., Goadsby, P. J., Guo, H., Miceli, R., Severt, L., Finnegan, M., & Trugman, J. M. (2021). Atogepant for the Preventive Treatment of Migraine. N Engl J Med, 385(8), 695-706. https://doi.org/10.1056/NEJMoa2035908

Albsoul-Younes, A. M., Salem, H. A., Ajlouni, S. F., & Al- Safi, S. A. (2004). Topiramate slow dose titration: improved efficacy and tolerability. Pediatr Neurol, 31(5), 349-352.

Alter, M., Daube, J. R., & Franklin, G. (1994). Practice parameter: the utility of neuroimaging in the evaluation of headache in patients with normal neurologic examinations ( summary statement). Report of the Quality Standards Subcommittee of the American Academy of Neurology, 44(7), 1353-1354.

Ambrosini, A., Vandenheede, M., & Rossi, P. (2005). Suboccipital injection with a mixture of rapid- and long-acting steroids in cluster headache: Adouble-blind placebo-controlled study. Pain(118(1-2)), 92-96. https://doi.org/10.1016/j.pain.2005.07.015

Anderson, P. G. (1975). Ergotamine headache. Headache, 15(2), 118-121. https://doi.org/10.1111/j.1526-4610.1975.hed1502118.x

Antonaci, F., Pareja, J., Caminero, A. B., & Sjaastad, O. (1998). Chronic paroxysmal hemicrania and hemicrania continua: lack of efficacy of sumatriptan. Headache, 38(3), 197-200.

Antonaci, F., & Sjaastad, O. (1989). Chronic paroxysmal hemicrania (CPH): a review of the clinical manifestations. Headache, 29(10), 648-656.

Arnold, M., Camus-Jacqmin, M., & Stapf, C. (2008). Postpartum cervicocephalic artery dissection. Stroke, 39(8), 2377-2379.

Asakura, H., Hayashi, Z., Seto, M., & Araki, T. (2001). Spontaneous intracranial hypotension during pregnancy. Obstet Gynecol, 97(5 Pt 2), 804-805. https://doi.org/10.1016/s0029-7844(00)01211-4

Ashina, M., Saper, J., Cady, R., Schaeffler, B. A., Biondi, D. M., Hirman, J., Pederson, S., Allan, B., & Smith, J. (2020).

Eptinezumab in episodic migraine: A randomized, double-blind, placebo-controlled study (PROMISE-1). Cephalalgia, 40(3), 241-254. https://doi.org/10.1177/0333102420905132

Ashkenazi, A., Matro, R., Shaw, J. W., Abbas, M. A., & Silberstein, S. D. (2008). Greater occipital nerve block using local anaesthetics alone or with triamcinolone for transformed migraine: a randomised comparative study. J Neurol Neurosurg Psychiatry, 79(4), 415-417.

Atasoy, H. T., Atasoy, N., Unal, A. E., Emre, U., & Sumer, M. (2005). Psychiatric comorbidity in medication overuse headache patients with pre-existing headache type of episodic tension-type headache. Eur J Pain, 9(3), 285-291.

Aurora, S. K., Dodick Dw Fau - Turkel, C. C., & Turkel Cc Fau - DeGryse, R. E. (2010). OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial. Cephalalgia, 30(7), 793-803. https://doi.org/10.1177/0333102410364676

Aygun, D., & Bildik, F. (2003). Clinical warning criteria in evaluation by computed tomography the secondary neurological headaches in adults. Eur J Neurol, 10(4), 437-442.

Backes, D., Rinkel, G. J., Kemperman, H., Linn, F. H., & Vergouwen, M. D. (2012). Time-dependent test characteristics of head computed tomography in patients suspected of nontraumatic subarachnoid hemorrhage. Stroke, 43(8), 2115-2119.

Bahra, A., & Goadsby, P. J. (2004). Diagnostic delays and mis-management in cluster headache. Acta Neurologica Scandinavica, 109(3), 175-179.

Bahra, A., May, A., & Goadsby, P. J. (2000). Diagnostic difficulties in cluster headache. Neurology, 109(3), 175-179. https://doi.org/10.1046/j.1600-0404.2003.00237.x

Bahra, A., May, A., & Goadsby, P. J. (2002). Cluster Headache : A prospective clinical study with diagnostic implications. Neurology, 58(3), 354-361.

Bahra, A., Walsh, M., Menon, S., & Goadsby, P. J. (2003). Does chronic daily headache arise de novo in association with regular analgesic use? Headache. 2003;43(3):179-190, 43(3), 179-190.

Balgera, R., Rigamonti, A., Sozzi, G., & Agostoni, E. (2009). An atypical case of spontaneous intracranial hypotension. Neurol Sci, 30(1), 71-73.

Barloese, M. C., Jennum, P. J., Lund, N. T., & Jensen, R. H. (2015). Sleep in cluster headache - beyond a temporal rapid eye movement relationship? Eur J Neurol, 22(4), 656-e640. https://doi.org/10.1111/ene.12623

Barloese, M. C., Jurgens, T. P., & May, A. (2016). Cluster headache attack remission with sphenopalatine ganglion stimulation: experiences in chronic cluster headache patients through 24 months. The Journal of Headache and Pain, 17(1), 67. https://doi.org/10.1186/s10194-016-0658-1

Bartolini, M., Silvestrini, M., & Taffi, R. (2005). Efficacy of topiramate and valproate in chronic migraine. Clin Neuropharmacol, 28(6), 277-279.

Bates, D., Ashford, E., & Dawson, R. (1994). Subcutaneous sumatriptan during migraine aura. Neurology, 44(9), 1587-1592.

Bendtsen, L., Jensen, R., & Olesen, J. (1996). A non-selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension-type headache. J Neurol Neurosurg Psychiatry, 61(3), 285-290.

Bigal, M. E., Bordini, C. A., & Speciali, J. G. (2002). Intravenous chlorpromazine in the emergency department treatment of migraines: a randomized controlled trial. J Emerg Med, 23(2), 141-148.

Bigal, M. E., & Lipton, R. B. (2006). Modifiable risk factors for migraine progression (or for chronic daily headaches)--clinical lessons. Headache, S144-146. https://doi.org/10.1111/j.1526-4610.2006.00566.x

Bigal, M. E., Lipton Rb Fau - Tepper, S. J., Tepper Sj Fau - Rapoport, A. M., Rapoport Am Fau - Sheftell, F. D., & Sheftell, F. D. (2004). Primary chronic daily headache and its subtypes in adolescents and adults. Neurology, 63(5), 643-647.

Bigal, M. E., Rapoport, A. M., Sheftell, F. D., Tepper, S. J., & Lipton, R. B. (2004). Transformed migraine and medication overuse in a tertiary headache centre--clinical characteristics and treatment outcomes. Cephalalgia, 24(6), 483-490.

Biousse, V., Woimant, F., Amarenco, P., Touboul, P. J., & Bousser, M. G. (1992). Pain as the only manifestation of internal carotid artery dissection. Cephalalgia, 12(5), 314-317.

Blau, N. J., & Dexter, S. L. (1981). The site of pain origin during migraine attacks. Cephalagia, 1(3), 143-147. https://doi.org/10.1046/j.1468-2982.1981.0103143.x

Blok, K. M., Rinkel, G. J., & Majoie, C. B. (2015). CT within 6 hours of headache onset to rule out subarachnoid hemorrhage in nonacademic hospitals. Neurology, 84(19), 1927-1932.

Blumenfeld, A. M., Varon, S. F., & Wilcox, T. K. (2011). Disability, HRQoL and resource use among chronic and episodic migraineurs: results from the International Burden of Migraine Study (IBMS). Cephalalgia, 31(3), 301-315.

Bøe, M. G., Mygland, A., & Salvesen, R. (2007). Prednisolone does not reduce withdrawal headache: a randomized, double-blind study. Neurology, 69(1), 26-31. https://doi.org/10.1212/01.wnl.0000263652.46222.e8

Boes, C. J., & Dodick, D. W. (2002). Refining the clinical spectrum of chronic paroxysmal hemicrania: a review of 74 patients. Headache, 42(8), 699-708. https://doi.org/10.1046/j.1526-4610.2002.02171.x

Brandes, J. L., Kudrow, D., & Stark, S. R. (2007). Sumatriptan-naproxen for acute treatment of migraine: a randomized trial. JAMA, 297(13), 1443-1454.

Brandes, J. L., Poole, A., & Kallela, M. (2009). Short-term frovatriptan for the prevention of difficult-to-treat menstrual migraine attacks. Cephalalgia, 29(11), 1133-1148.

Brandes, J. L., Saper, J. R., & Diamond, M. (2004). Topiramate for migraine prevention: a randomized controlled trial. JAMA, 291(8), 965-973.

Broadley, S. A., Park, N., Renowden, S., & Ferguson, I. T. (2005). Unusual cause of sudden onset headache: spontaneous intracranial hypotension. Emerg Med Australas, 17(5-6), 520-523. https://doi.org/10.1111/j.1742-6723.2005.00785.x

Bussone, G., Leone, M., & Peccarisi, C. (1990). Double- blind comparison of lithium and verapamil in cluster headache prophylaxis. Headache, 30(7), 411-417.

Buyle, M., Engelborghs, S., Kunnen, J., & De Deyn, P. P. (2001). Headache as only symptom in multiple cervical artery dissection. Headache, 41(5), 509-511.

Cady, R. K., Gutterman, D., Saiers, J. A., & Beach, M. E. (1997). Responsiveness of non-IHS migraine and tension-type headache to sumatriptan. Cephalalgia, 17(5), 588-590.

Castillo, J., Muñoz, P., Guitera, V., & Pascual, J. (1999). Kaplan Award 1998. Epidemiology of chronic daily headache in the general population. Headache, 39(3), 190-196. https://doi.org/10.1046/j.1526-4610.1999.3903190.x

Cevoli, S., Giannini, G., & Favoni, V. (2017). Treatment of withdrawal headache in patients with medication overuse headache: a pilot study. J Headache Pain, 18(1), 56. https://doi.org/10.1186/s10194-017-0763-9

Cittadini, E., & Goadsby, P. J. (2010). Hemicrania continua: a clinical study of 39 patients with diagnostic implications. Brain, 133(7), 1973-1986.

Cittadini, E., Matharu, M. S., & Goadsby, P. J. (2008). Paroxysmal hemicrania: a prospective clinical study of 31 cases. Brain, 131, 1142-1155. https://doi.org/10.1093/brain/awn010

Cittadini, E., May, A., Straube, A., Evers, S., Bussone, G., & Goadbsy, P. J. (2006). Effectiveness of intranasal zolmitriptan in acute cluster headache: a randomised placebo-controlled crossover study. Archives of Neurology, 63(11), 1537-1542.

Cohen, A. S., Burns, B., & Goadsby, P. J. (2009). High-flow oxygen for treatment of cluster headache: a randomized trial. JAMA, 302(22), 2451-2457. https://doi.org/10.1001/jama.2009.1855

Cohen, A. S., Matharu, M. S., & Goadsby, P. J. (2006). Short- lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT) or cranial autonomic features (SUNA)--a prospective clinical study of SUNCT and SUNA. Brain, 129(10), 2746-2760.

Cohen, A. S., Matharu, M. S., & Goadsby, P. J. (2007). Electrocardiographic abnormalities in patients with cluster headache on verapamil therapy. Neurology, 69(7), 668-675.

Cortelli, P., Allais, G., & Tullo, V. (2011). Frovatriptan versus other triptans in the acute treatment of migraine: pooled analysis of three double-blind, randomized, cross-over, multicenter, Italian studies. Neurol Sci, 32, S95-98. https://doi.org/10.1007/s10072-011-0551-2

Cortez, O., Schaeffer, C. J., Hatem, S. F., Glauser, J., & Ahmed, M. (2009). Cases from the Cleveland Clinic: cerebral venous sinus thrombosis presenting to the emergency department with worst headache of life. Emerg Radiol, 16(1), 79-82.

Cortijo, E., Guerrero Al Fau - Herrero, S., & Herrero, S. F. M. P. (2012). Hemicrania continua in a headache clinic: referral source and diagnostic delay in a series of 22 patients. Journal of Headache and Pain, 13(7), 567-569.

Cosentino, G., Fierro, B. F. P. A. R., Puma Ar Fau - Talamanca, S., Talamanca, S. F. B. F., & Brighina, F. (2010). Different forms of trigeminal autonomic cephalalgias in the same patient: description of a case. Journal of Headache and Pain, 11(3), 281-284.

Couch, J. R., & Hassanein, R. S. (1979). Amitriptyline in migraine prophylaxis. Arch Neurol, 36(11), 695-699.

Couch, J. R., & Ziegler, D. K. (1978). Prednisone therapy for cluster headache. Headache, 18(4), 219-221. https://doi.org/10.1111/j.1526-4610.1978.hed1804219.x

Couturier, E. G., Bomhof, M. A., Neven, A. K., & van Duijn, N. P. (2003). Menstrual migraine in a representative Dutch population sample: prevalence, disability and treatment. Cephalalgia, 23(4), 302-308.

Cox, L. K., Bertorini, T., & Laster, R. E. (1991). Headaches due to spontaneous internal carotid artery dissection magnetic resonance imaging evaluation and follow up. Headache, 31(1), 12-16.

Croop, R., Goadsby, P. J., Stock, D. A., Conway, C. M., Forshaw, M., Stock, E. G., Coric, V., & Lipton, R. B. (2019). Efficacy, safety, and tolerability of rimegepant orally disintegrating tablet for the acute treatment of migraine: a randomised, phase 3, double-blind, placebo-controlled trial. Lancet, 394(10200), 737-745. https://doi.org/10.1016/s0140-6736(19)31606-x

Croop, R., Lipton, R. B., Kudrow, D., Stock, D. A., Kamen, L., Conway, C. M., Stock, E. G., Coric, V., & Goadsby, P. J. (2021). Oral rimegepant for preventive treatment of migraine: a phase 2/3, randomised, double-blind, placebo-controlled trial. Lancet, 397(10268), 51-60. https://doi.org/10.1016/s0140-6736(20)32544-7

Cruickshank, A., Auld, P., & Beetham, R. (2008). Revised national guidelines for analysis of cerebrospinal fluid for bilirubin in suspected subarachnoid haemorrhage. Ann Clin Biochem, 45, 238-244. https://doi.org/10.1258/acb.2008.007257

Cryer, R. J., & Ferriman, D. (1971). Pituitary apoplexy. Proc R Soc Med, 64(3), 301-302.

Cuadrado, M. L., Aledo-Serrano, A., & Navarro, P. (2017). Short-term effects of greater occipital nerve blocks in chronic migraine: A double-blind, randomised, placebo-controlled clinical trial. Cephalalgia, 37(9), 864-872.

D'Amico, D., Leone, M., & Bussone, G. (1994). Side-locked unilaterality and pain localization in long-lasting headaches: migraine, tension-type headache, and cervicogenic headache. Headache, 34(9), 526-530.

Dahlöf, C. (1993). Subcutaneous sumatriptan does not abort attacks of chronic paroxysmal hemicrania (CPH). Headache, 33(4), 201-202. https://doi.org/10.1111/j.1526-4610.1993.hed33040201.x

Dahlöf, C., & Bj rkman, R. (1993). Diclofenac-K (50 and 100 mg) and placebo in the acute treatment of migraine. Cephalalgia, 13(2), 117-123.

Dahlöf, C. G. (2006). Infrequent or non-response to oral sumatriptan does not predict response to other triptans--review of four trials. Cephalalgia, 26(2), 98-106.

Dahlöf, C. G., & Jacobs, L. D. (1996). Ketoprofen, paracetamol and placebo in the treatment of episodic tension-type headache. Cephalalgia, 16(2), 117-123. https://doi.org/10.1046/j.1468-2982.1996.1602117.x

Daniel, O., Tepper, S. J., Deutsch, L., & Sharon, R. (2022). External Concurrent Occipital and Trigeminal Neurostimulation Relieves Migraine Headache: A Prospective, Randomized, Double-Blind, Sham-Controlled Trial. Pain Ther, 11(3), 907-922. https://doi.org/10.1007/s40122-022-00394-w

Davies, P. T., Peatfield, R. C., Steiner, T. J., Bond, R. A., & Clifford Rose, F. (1991). Some clinical comparisons between common and classical migraine: a questionnaire-based study. Cephalalgia, 11(5), 223-227.

de Bruijn, S. F., Stam, J., & Kappelle, L. J. (1996). Thunderclap headache as first symptom of cerebral venous sinus thrombosis. Lancet, 348(9042), 1623-1625. https://doi.org/10.1016/s0140-6736(96)07294-7

de Lignières, B., Vincens, M., Mauvais-Jarvis, P., Mas, J. L., Touboul, P. J., & Bousser, M. G. (1986). Prevention of menstrual migraine by percutaneous oestradiol. Br Med J (Clin Res Ed), 293(6561), 1540. https://doi.org/10.1136/bmj.293.6561.1540

Dennerstein, L., Morse, C., Burrows, G., Oats, J., Brown, J., & Smith, M. (1988). Menstrual migraine: A double- blind trial of percutaneous estradiol. Gynecological Endocrinology, 2(2), 113-120.

Derry, C. J., Derry, S., & Moore, R. A. (2012). Sumatriptan (intranasal route of administration) for acute migraine attacks in adults. Cochrane Database Syst Rev.

Derry, C. J., Derry, S., & Moore, R. A. (2014). Sumatriptan (all routes of administration) for acute migraine attacks in adults - overview of Cochrane reviews. Cochrane Database Syst Rev.

Derry, S., & Moore, R. A. (2013). Paracetamol (acetaminophen) with or without an antiemetic for acute migraine headaches in adults. Cochrane Database Syst Rev.

Derry, S., Rabbie, R., & Moore, R. A. (2013). Diclofenac with or without an antiemetic for acute migraine headaches in adults. Cochrane Database Syst Rev.

Derry, S., Wiffen, P. J., & Moore, R. A. (2017). Aspirin for acute treatment of episodic tension-type headache in adults. Cochrane Database Syst Rev.

Derry, S., Wiffen, P. J., Moore, R. A., & Bendtsen, L. (2015). Ibuprofen for acute treatment of episodic tension- type headache in adults. Cochrane Database Syst Rev.

Detke, H. C., Goadsby, P. J., Wang, S., Friedman, D. I., Selzler, K. J., & Aurora, S. K. (2018). Galcanezumab in chronic migraine: The randomized, double-blind, placebo- controlled REGAIN study. Neurology, 91(24), e2211-e2221. https://doi.org/10.1212/WNL.0000000000006640

Devenney, E., Neale, H., & Forbes, R. B. (2014). A systematic review of causes of sudden and severe headache (Thunderclap Headache): should lists be evidence based? . J Headache Pain, 15(1), 49. https://doi.org/10.1186/1129-2377-15-49

Diamond, S. (1983). Ibuprofen versus aspirin and placebo in the treatment of muscle contraction headache. Headache, 23(5), 206-210.

Diamond, S., & Baltes, B. J. (1971). Chronic tension headache--treated with amitriptyline--a double- blind study. Headache, 11(3), 110-116.

Dib, M., Massiou, H., & Weber, M. (2002). Efficacy of oral ketoprofen in acute migraine: a double-blind randomized clinical trial. Neurology, 58(11), 1660-1665.

Diener, H. C., Agosti, R., & Allais, G. (2007). Cessation versus continuation of 6-month migraine preventive therapy with topiramate (PROMPT): a randomised, double-blind, placebo-controlled trial. Lancet Neurol, 6(12), 1054-1062.

Diener, H. C., Bussone, G., & de Liano, H. (2004). Placebo-controlled comparison of effervescent acetylsalicylic acid, sumatriptan and ibuprofen in the treatment of migraine attacks. Cephalalgia, 24(11), 947-954.

Diener, H. C., Bussone, G., & Van Oene, J. C. (2007). Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo- controlled study. Cephalalgia, 27(7), 814-823. https://doi.org/10.1111/j.1468-2982.2007.01326.x

Diener, H. C., & Dahlof, C. (1999). Headache associated with chronic use of substances. In: Olesen J, Tfelt- Hansen P, Welch KMA, eds.

Diener, H. C., Dodick Dw Fau - Aurora, S. K., & Aurora Sk Fau - Turkel, C. C. (2010). OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial. Cephalalgia, 30(7), 804-814. https://doi.org/10.1177/0333102410364677

Diener, H. C., Jansen, J. P., & Reches, A. (2002). Efficacy, tolerability and safety of oral eletriptan and ergotamine plus caffeine (Cafergot) in the acute treatment of migraine: a multicentre, randomised, double-blind, placebo-controlled comparison. European Neurology, 47(2), 99-107.

Diener, H. C., & Limmroth, V. (2004). Medication-overuse headache: a worldwide problem. Lancet Neurol, 3(8), 475-483.

Diener, H. C., Tfelt-Hansen, P., & Dahl f, C. (2004). Topiramate in migraine prophylaxis--results from a placebo-controlled trial with propranolol as an active control. J Neurol, 251(8), 943-950.

Dilli, E., Halker, R., & Vargas, B. (2015). Occipital nerve block for the short-term preventive treatment of migraine: A randomized, double-blinded, placebo- controlled study. Cephalalgia, 35(11), 959-968. https://doi.org/10.1177/0333102414561872

Dodick, D. (2003). Diagnosing headache: clinical clues and clinical rules. Advanced Studies in Medicine, 3(2), 87-92.

Dodick, D., Brandes, J., Elkind, A., Mathew, N., & Rodichok, L. (2005). Speed of onset, efficacy and tolerability of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double- blind, placebo-controlled study. CNS Drugs, 19(2), 125-136.

Dodick, D., Lipton, R. B., & Martin, V. (2004). Consensus statement: cardiovascular safety profile of triptans (5-HT agonists) in the acute treatment of migraine. Headache, 44(5), 414-425.

Dodick, D. W., Ashina, M., & Brandes, J. L. (2018). ARISE: A Phase 3 randomized trial of erenumab for episodic migraine. Cephalalgia, 38(6), 1026-1037. https://doi.org/10.1177/0333102418759786

Dodick, D. W., Freitag, F., & Banks, J. (2009). Topiramate versus amitriptyline in migraine prevention: a 26- week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs. Clin Ther, 31(3), 542-559. https://doi.org/10.1016/j.clinthera.2009.03.020

Dodick, D. W., & Silberstein, S. D. (2008). How clinicians can detect, prevent and treat medication overuse headache. Cephalalgia, 28(11), 1207-1217.

Dodick, D. W., Turkel, C. C., & DeGryse, R. E. (2010). OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program. Headache, 50(6), 921-936.

Dodick, D. W., & Wijdicks, E. F. (1998). Pituitary apoplexy presenting as a thunderclap headache. Neurology, 50(5), 1510-1511.

Donegan, S., Dixon, P., Hemming, K., Tudur-Smith, C., & Marson, A. (2015). A systematic review of placebo- controlled trials of topiramate: How useful is a multiple-indications review for evaluating the adverse events of an antiepileptic drug? . Epilepsia, 56(12), 1910-1920.

Donnet, A., Lanteri-Minet, M., & Guegan-Massardier, E. (2007). Chronic cluster headache: a French clinical descriptive study. J Neurol Neurosurg Psychiatry, 78(12), 1354-1358.

Edlow, J. A., Panagos, P. D., Godwin, S. A., Thomas, T. L., Decker, W. W., & Physicians, A. (2008). Clinical policy: critical issues in the evaluation and management of adult patients presenting to the emergency department with acute headache. Ann Emerg Med, 52(4), 407-436.

Edmeads, J. (2005). Defining response in migraine: which endpoints are important? Eur Neurol, 53, 22-28.

Ekbom, K. (1968). Nitroglycerin as a provocative agent in cluster headache. Arch Neurol, 19(5), 487-493. https://doi.org/10.1001/archneur.1968.00480050057005

Ekbom, K. (1970a). A clinical comparison of cluster headache and migraine. Acta Neurologica Scandinavica, 1+.

Ekbom, K. (1970b). Patterns of cluster headache with a note on the relations to angina pectoris and peptide ulcer. Acta Neurol Scand, 46(2), 225-237. https://doi.org/10.1111/j.1600-0404.1970.tb05618.x

Ekbom, K., & Cole, J. A. (1993). Subcutaneous sumatriptan in the acute treatment of cluster headache attacks. Canadian Journal of Neurological Sciene, 88(1), 63-69. https://doi.org/10.1111/j.1600-0404.1993.tb04189.x

Ekbom, K., & Group, T. (1991). Treatment of acute cluster headache with sumatriptan. The New England journal of medicine, 325(5), 322-326. https://doi.org/10.1056/NEJM199108013250505

Ekbom, K., Krabbe, A. F. M. G., & Micieli, G. F. P. A. (1995). Cluster headache attacks treated for up to three months with subcutaneous sumatriptan (6 mg). Sumatriptan Cluster Headache Long-term Study Group. Cephalagia, 15(3), 230-236. https://doi.org/10.1046/j.1468-2982.1995.015003230.x

Endres, H. G., G, B. w., & Diener, H. C. (2007). Acupuncture for tension-type headache: a multicentre, sham-controlled, patient-and observer-blinded, randomised trial. J Headache Pain, 8(5), 306-314.

Ephross, S. A., & Sinclair, S. M. (2014). Final results from the 16-year sumatriptan, naratriptan, and treximet pregnancy registry. Headache, 54(7), 1158-1172. https://doi.org/10.1111/head.12375

Epstein, S., Pimstone, B. L., De Villiers, J. C., & Jackson, W. P. (1971). Pituitary apoplexy in five patients with pituitary tumours. Br Med J, 2(5756), 267-270. https://doi.org/10.1136/bmj.2.5756.267

Espinosa, P. S., Choudry, B., Wilbourn, R., Espinosa, P. H., & Vaishnav, A. G. (2007). Pituitary apoplexy: a neurological emergency case report. J Ky Med Assoc, 105(11), 538-540.

Evers, S., Savi, L., Omboni, S., Lisotto, C., Zanchin, G., & Pinessi, L. (2015). Efficacy of frovatriptan as compared to other triptans in migraine with aura. J Headache Pain, 16, 514. https://doi.org/10.1186/s10194-015-0514-8

Famularo, G., Minisola, G., & Gigli, R. (2005). Thunderclap headache and spontaneous intracranial hypotension. Headache, 45(4), 392-393.

Favoni, V., Grimaldi, D., Pierangeli, G., Cortelli, P., & Cevoli, S. (2013). SUNCT/SUNA and neurovascular compression: new cases and critical literature review. Cephalalgia, 33(16), 1337-1348.

Feigin, V. L., Abajobir, A. A., Abate, K. H., Abd-Allah, F., Abdulle, A. M., Abera, S. F., Abyu, G. Y., Ahmed, M. B., Aichour, A. N., Aichour, I., Aichour, M. T. E., Akinyemi, R. O., Alabed, S., Al-Raddadi, R., Alvis-Guzman, N., Amare, A. T., Ansari, H., Anwari, P., Ärnlöv, J.,…Vos, T. (2017). Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet Neurology, 16(11), 877-897. https://doi.org/10.1016/S1474-4422(17)30299-5

Ferrante, E., & Savino, A. (2005). Thunderclap headache caused by spontaneous intracranial hypotension. Neurol Sci, 26, s155-157. https://doi.org/10.1007/s10072-005-0433-6

Ferrante, T., Manzoni, G. C., & Russo, M. (2013). Prevalence of tension-type headache in adult general population: the PACE study and review of the literature. Neurol Sci, 34, S137-138. https://doi.org/10.1007/s10072-013-1370-4

Ferrari, M. D., Roon, K. I., Lipton, R. B., & Goadsby, P. J. (2001). Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials. Lancet, 358(9294), 1668-1675.

Fink, M., Gutenbrunner, C., Rollnik, J., & Karst, M. (2001). Credibility of a newly designed placebo needle for clinical trials in acupuncture research. Forsch Komplementarmed Klass Naturheilkd, 8(6), 368-372.

Fischera, M., Marziniak, M., Gralow, I., & Evers, S. (2008). The incidence and prevalence of cluster headache: a meta-analysis of population-based studies. Cephalalgia, 28(6), 614-618.

Fisher, C. M. (1982). The headache and pain of spontaneous carotid dissection. Headache, 22(2), 60-65.

Fishman, R. (1980). Cerebrospinal Fluid in Diseases of the Nervous System.

Fogan, L. (1985). Treatment of cluster headache. Archives of Neurology, 42(4), 362-363.

Freitag, F. G., Collins, S. D., & Carlson, H. A. (2002). A randomized trial of divalproex sodium extended- release tablets in migraine prophylaxis. Neurology, 58(11), 1652-1659.

Friedman, A. P., & Mikropoulos, H. E. (1958). Cluster headaches. Neurology (Minneapolis), 8(9), 653-663. https://doi.org/10.1212/wnl.8.9.653

Friedman, B. W., Esses, D., & Solorzano, C. (2008). A randomized controlled trial of prochlorperazine versus metoclopramide for treatment of acute migraine. Ann Emerg Med, 52(4), 399-406.

Friedman, B. W., Mulvey, L., & Esses, D. (2011). Metoclopramide for acute migraine: a dose- finding randomized clinical trial. Ann Emerg Med, 57(5), 475-482.

Fritsche, G., & Diener, H. C. (2002). Medication overuse headaches -- what is new? Expert Opin Drug Saf, 1(4), 331-338. https://doi.org/10.1517/14740338.1.4.331

Garza, I., & Kirsch, J. (2007). Pituitary apoplexy and thunderclap headache. Headache, 47(3), 431-432.

Gaul, C., Liesering-Latta, E., Schafer, B., Fritsche, G., & Holle, D. (2016). Integrated multidisciplinary care of headache disorders: A narrative review. Cephalalgia, 36(12), 1181-1191.

Giffin, N. J., Lipton, R. B., Silberstein, S. D., Olesen, J., & Goadsby, P. J. (2016). The migraine postdrome: An electronic diary study. Neurology, 87(3), 309-313.

Giffin, N. J., Ruggiero, L., Lipton, R. B., Silberstein, S. D., Tvedskov, J. F., Olesen, J., Altman, J., Goadsby, P. J., & Macrae, A. (2003). Premonitory symptoms in migraine: an electronic diary study. Neurology, 60(6), 935-940. https://doi.org/10.1212/01.wnl.0000052998.58526.a9

Goadsby, P. J., de Coo, I. F., & Silver, N. (2018). Non- invasive vagus nerve stimulation for the acute treatment of episodic and chronic cluster headache: A randomized, double-blind, sham- controlled ACT2 study. Cephalalgia, 38(5), 959-969.

Goadsby, P. J., Friedman, D. I., Holle-Lee, D., Demarquay, G., Ashina, S., Sakai, F., Neel, B., Gandhi, P., Dabruzzo, B., Smith, J. H., Liu, Y., & Trugman, J. M. (2024). Efficacy of Atogepant in Chronic Migraine With and Without Acute Medication Overuse in the Randomized, Double-Blind, Phase 3 PROGRESS Trial. Neurology, 103(2), e209584. https://doi.org/10.1212/wnl.0000000000209584

Goadsby, P. J., & Lipton, R. B. (1997). A review of paroxysmal hemicranias, SUNCT syndrome and other short- lasting headaches with autonomic feature, including new cases. Brain, 120, 193-209. https://doi.org/10.1093/brain/120.1.193

Goadsby, P. J., Reuter, U., & Hallstr m, Y. (2017). A Controlled Trial of Erenumab for Episodic Migraine. N Engl J Med, 377, 2123-2132. https://doi.org/10.1056/NEJMoa1705848

Goadsby, P. J., Sahai-Srivastava, S., Kezirian, E. J., Calhoun, A. H., Matthews, D. C., & Pj, M. (2018). Sphenopalatine Ganglion Stimulation is Effective for Chronic Cluster Headache - A Sham- Controlled Study (Abstract). 60th Annual Scientific Meeting American Headache Society June 28 July 1, 2018 Marriott Marquis San Francisco San Francisco, CA, 58(8), 1316-1317.

Goadsby, P. J., Zanchin, G., Geraud, G., de Klippel, N., Diaz-Insa, S., Gobel, H., Cunha, L., Ivanoff, N., Falques, M., & Fortea, J. (2008). Early vs. non-early intervention in acute migraine-'Act when Mild (AwM)'. A double-blind, placebo-controlled trial of almotriptan. Cephalalgia, 28(4), 383-391. https://doi.org/10.1111/j.1468-2982.2008.01546.x

Gobel, H., Lindner, A., Ribbat, M., & Deuschl, G. (1998). Acute therapy for cluster headache with sumatriptan: Findings of a one-year long-term study. Neurology, 51(3), 908-911. https://doi.org/10.1212/wnl.51.3.908

Goldstein, J., Silberstein, S. D., & Saper, J. R. (2005). Acetaminophen, aspirin, and caffeine versus sumatriptan succinate in the early treatment of migraine: results from the ASSET trial. Headache, 45(8), 973-982.

Grande, R. B., Aaseth, K., Benth, J., Lundqvist, C., & Russell, M. B. (2011). Reduction in medication-overuse headache after short information. The Akershus study of chronic headache. Eur J Neurol, 18(1), 129-137. https://doi.org/10.1111/j.1468-1331.2010.03094.x

Granella, F., Sances, G., Pucci, E., Nappi, R. E., Ghiotto, N., & Napp, G. (2000). Migraine with aura and reproductive life events: a case control study. Cephalalgia, 20(8), 701-707.

Granella, F., Sances, G., Zanferrari, C., Costa, A., Martignoni, E., & Manzoni, G. C. (1993). Migraine without aura and reproductive life events: a clinical epidemiological study in 1300 women. Headache, 33(7), 385-389.

Guo, Y., Han, X., Yu, T., & Yao, G. (2012). Meta-analysis of efficacy of topiramate in migraine prophylaxis. Neural Regen Res, 7(23), 1806-1811.

Hamilton, W., & Kernick, D. (2007). Clinical features of primary brain tumours: a case-control study using electronic primary care records. Br J Gen Pract, 57(542), 695-699.

Havanka-Kanniainen, H. (1989). Treatment of acute migraine attack: ibuprofen and placebo compared. Headache, 29(8), 507-509.

He, R. H. (1983). [Acute pituitary vascular accident (pituitary apoplexy)]. Zhonghua Nei Ke Za Zhi, 22(4), 228-230.

Hedlund, C., Rapoport Am Fau - Dodick, D. W., Dodick Dw Fau - Goadsby, P. J., & Goadsby, P. J. (2009). Zolmitriptan nasal spray in the acute treatment of cluster headache: a meta-analysis of two studies. Headache, 49(9), 1315-1323.

Heo, Y. E., Kwon, H. M., & Nam, H. W. (2009). Thunderclap headache as an initial manifestation of phaeochromocytoma. Cephalalgia, 29(3), 388-390.

Hering-Hanit, R. (2000). Alteration in nature of cluster headache during subcutaneous administration of sumatriptan. Headache, 40(1), 41-44.

Hering, R., & Kuritzky, A. (1992). Sodium valproate in the prophylactic treatment of migraine : a double- blind study versus placebo. Cephalagia, 12(2), 81-84. https://doi.org/10.1046/j.1468-2982.1992.1202081.x

Holroyd, K. A., O'Donnell, F. J., Stensland, M., Lipchik, G. L., Cordingley, G. E., & Carlson, B. W. (2001). Management of chronic tension-type headache with tricyclic antidepressant medication, stress management therapy, and their combination: a randomized controlled trial. JAMA, 285(17), 2208-2215.

Hornabrook, R. W. (1964). Migrainous neuralgia. New Zealand Medical Journal, 63, 774-779.

Howard, L. (2005). Are investigations anxiolytic or anxiogenic? A randomised controlled trial of neuroimaging to provide reassurance in chronic daily headache. Journal of Neurology, Neurosurgery & Psychiatry, 76(11), 1558-1564. https://doi.org/10.1136/jnnp.2004.057851

Ikeda, K., Matsumori, Y., Kudo, M., Ishikawa, T., Hoshino, Y., Yoshimatsu, H., Thiry, A., Arakawa, A., Croop, R., Fullerton, T., Sakai, F., & Takeshima, T. (2025). Efficacy and safety of rimegepant for the acute treatment of migraine in Japan: A dose-ranging, double-blind, randomized controlled trial. Headache, 65(10), 1811-1820. https://doi.org/10.1111/head.14994

Inan, L. E., Inan, N., & Karadas, O. (2015). Greater occipital nerve blockade for the treatment of chronic migraine: a randomized, multicenter, double-blind, and placebo-controlled study. Acta Neurol Scand, 132(4), 270-277.

Iversen, H. K., Langemark, M., Andersen, P. G., Hansen, P. E., & Olesen, J. (1990). Clinical characteristics of migraine and episodic tension-type headache in relation to old and new diagnostic criteria. Headache, 30(8), 514-519. https://doi.org/10.1111/j.1526-4610.1990.hed3008514.x

Jackson, J. L., Shimeall, W., & Sessums, L. (2010). Tricyclic antidepressants and headaches: systematic review and meta-analysis. Bmj, 20(314), c5222. https://doi.org/10.1136/bmj.c5222

Jaiser, S. R., Raman, A., & Maddison, P. (2008). Cerebral venous sinus thrombosis as a rare cause of thunderclap headache and nonaneurysmal subarachnoid haemorrhage. J Neurol, 255(3), 448-449.

Jammes, J. L. (1975). The treatment of cluster headaches with prednisone. Diseases of the Nervous System, 36(7), 375-376.

Johannsson, V., Nilsson, L. R., & Widelius, T. (1987). Atenolol in migraine prophylaxis a double-blind cross-over multicentre study. Headache, 27(7), 372-374.

Johnson, E. S., Ratcliffe, D. M., & Wilkinson, M. (1985). Naproxen sodium in the treatment of migraine. Cephalalgia, 5(1), 5-10.

Joo, I. S., & Lee, J. S. (2005). Dissecting aneurysm of the basilar artery as a cause of orgasmic headache. Headache, 45(7), 956-959.

Joubert, J. (1991). Hemicrania continua in a black patient-the importance of the non-continuous stage. Headache, 31(7), 480-482.

Kangasniemi, P., & Hedman, C. (1984). Metoprolol and propranolol in the prophylactic treatment of classical and common migraine. A double-blind study. Cephalagia, 4(2), 91-96. https://doi.org/10.1046/j.1468-2982.1984.0402091.x

Kaniecki, R. G. (1997). A comparison of Divalproex with propranolol and placebo for the prophylaxis of migraine without aura. Archives of Neurology, 54(9), 1141-1145. https://doi.org/10.1001/archneur.1997.00550210071015

Katsarava, Z., Fritsche, G., Muessig, M., Diener, H. C., & Limmroth, V. (2001). Clinical features of withdrawal headache following overuse of triptans and other headache drugs. Neurology, 57(9), 1694-1698. https://doi.org/10.1212/wnl.57.9.1694

Katsarava, Z., Meussig, M., Dzagnidze, A., Fritsche, G., Diener, H. C., & Limmroth, V. (2005). Medication overuse headache: rates and predictors for relapse in a 4 year prospective study. Cephalalgia, 25(1), 12-15.

Katzman, G. L., Dagher, A. P., & Patronas, N. J. (1999). Incidental findings on brain magnetic resonance imaging from 1000 asymptomatic volunteers. JAMA: The Journal of the American Medical Association, 282(1), 36-39.

Kaube, H., May, A., & Pfaffenrath, V. (1994). Sumatriptan [letter; comment]. Bmj, 308(6943), 1573-1574. https://doi.org/10.1136/bmj.308.6943.1573d

Kelly, A. M., Walcynski, T., & Gunn, B. (2009). The relative efficacy of phenothiazines for the treatment of acute migraine: a meta-analysis. Headache, 49(9), 1324-1332.

Kelman, L. (2005). Migraine Pain Location: A Tertiary Care Study of 1283 Migraineurs. Headache, 45(8), 1038-1047.

Kelman, L. (2006). Pain characteristics of the acute migraine attack. Headache, 46(6), 942-953. https://doi.org/10.1111/j.1526-4610.2006.00443.x

Kernick, D. P., Ahmed, F., & Bahra, A. (2008). Imaging patients with suspected brain tumour: guidance for primary care. Br J Gen Pract, 58(557), 880-885.

Khalil, M., Zafar, H. W., Quarshie, V., & Ahmed, F. (2014). Prospective analysis of the use of OnabotulinumtoxinA (BOTOX) in the treatment of chronic migraine; real-life data in 254 patients from Hull, UK. J Headache Pain, 15(54). https://doi.org/10.1186/1129-2377-15-54

Kindelan-Calvo, P., Gil-Mart nez, A., & Paris-Alemany, A. (2014). Effectiveness of therapeutic patient education for adults with migraine. A systematic review and meta-analysis of randomized controlled trials. Pain Med, 15(9), 1619-1636. https://doi.org/10.1111/pme.12505

Kirthi, V., Derry, S., & Moore, R. A. (2013). Aspirin with or without an antiemetic for acute migraine headaches in adults. Cochrane Database Syst Rev.

Klapper, J. (1997). Divalproex sodium in migraine prophylaxis: a dose-controlled study. Cephalagia, 17(2), 103-108. https://doi.org/10.1046/j.1468-2982.1997.1702103.x

Klassen, A., Elkind, A., Asgharnejad, M., Webster, C., & Laurenza, A. (1997). Naratriptan is effective and well tolerated in the acute treatment of migraine. Results of a double-blind, placebo-controlled, parallel-group study. Headache, 37(10), 640-645. https://doi.org/10.1046/j.1526-4610.1997.3710640.x

Kloster, R., Nestvold, K., & Vilming, S. T. (1992). A double-blind study of ibuprofen versus placebo in the treatment of acute migraine attacks. Cephalalgia, 12(3), 169-171.

Kong, X., Chen, J., & Jiang, H. (2018). Testing of diagnosis criteria of tension-type headache: A multicenter clinical study. Cephalalgia, 38(12), 1833-1840. https://doi.org/10.1177/0333102418759784

Köseoglu, E., Talaslioglu, A., Gönül, A. S., & Kula, M. (2008). The effects of magnesium prophylaxis in migraine without aura. Magnes Res, 21(2), 101-108.

Krymchantowski, A., & Moreira, P. (2003). Out-patient detoxification in chronic migraine: comparison of strategies. Cephalalgia, 23(10), 982-993.

Krymchantowski, A. V. (2005). Aura with non-migraine headache. Current Pain and Headache Reports, 9(4), 264-267.

Kubitzek, F., Ziegler, G., Gold, M. S., Liu, J. M., & Ionescu, E. (2003). Low-dose diclofenac potassium in the treatment of episodic tension-type headache. Eur J Pain, 7(2), 155-162.

Kudrow, L. (1980). Cluster Headache: Mechanisms and Management.

Kudrow, L. (1982). Paradoxical effects of frequent analgesic use. Advances in Neurology, 33, 335-341.

Kudrow, L. (1987). The cylic relationship of natural illumination to cluster period frequency. Cephalalgia, 7(6), 76-78.

Kuhn, J., Kuhn, K. F., Cooper-Mahkorn, D., & Bewermeyer, H. (2005). Remitting form of hemicrania continua: two new cases exhibiting one unusual autonomic feature. Headache, 45(6), 759-762. https://doi.org/10.1111/j.1526-4610.2005.05143_4.x

Kurth, T., Buring, J. E., & Rist, P. M. (2015). Headache, migraine and risk of brain tumors in women: prospective cohort study. J Headache Pain, 16(1), 501. https://doi.org/10.1186/s10194-015-0501-0.

Kurth, T., Slomke, M. A., & Kase, C. S. (2005). Migraine, headache, and the risk of stroke in women. Neurology, 64(6), 1020-1026. https://doi.org/10.1212/01.WNL.0000154528.21485.3A

Kuzma, B. B., & Goodman, J. M. (1999). Sudden headache with pituitary infarction. Surg Neurol, 52(5), 532-533. https://doi.org/10.1016/s0090-3019(99)00107-x

Lance, F., Parkes, C., & Wilkinson, M. (1988). Does analgesic abuse cause headaches de novo. Headache, 28(1), 61-62. https://doi.org/10.1111/j.1526-4610.1988.hed2801060_2.x

Lance, J. W., & Anthony, M. (1966). Some clinical aspects of migraine: A prospective survery of 500 patients. Archives of Neurology, 15(4), 356-361. https://doi.org/10.1001/archneur.1966.00470160022003

Lance, J. W., & Anthony, M. (1971). Migrainous neuralgia or cluster headache? . Journal of the Neurological Sciences, 13, 401-414.

Landtblom, A. M., Fridriksson, S., Boivie, J., Hillman, J., Johansson, G., & Johansson, I. (2002). Sudden onset headache: a prospective study of features, incidence and causes. Cephalalgia, 22(5), 354-360.

Langemark, M., & Olesen, J. (1987). Effervescent ASA versus solid ASA in the treatment of tension headache. A double-blind, placebo controlled study, 27(2), 90-95.

Lanteri-Minet, M., Silhol, F. F. P. V., Piano, V. F. D. A., & Donnet, A. (2011). Cardiac safety in cluster headache patients using the very high dose of verapamil (>/=720 mg/day). Journal of Headache and Pain, 12(2), 173-176.

Laughey, W. F., Holmes, W. F., MacGregor, A. E., & Sawyer, J. P. C. (1999). Headache consultation and referral patterns in one UK general practice. Cephalalgia, 19(4), 328-329.

Law, S., Derry, S., & Moore, R. A. (2013). Naproxen with or without an antiemetic for acute migraine headaches in adults. Cochrane Database Syst Rev.

Law, S., Derry, S., & Moore, R. A. (2016). Sumatriptan plus naproxen for the treatment of acute migraine attacks in adults. Cochrane Database Syst Rev.

Law, S., Derry, S. F. M. R. A., & Moore, R. A. (2010). Triptans for acute cluster headache. Cochrane Database Syst Rev.

Leira, E. C., Cruz-Flores, S., Leacock, R. O., & Abdulrauf, S. I. (2001). Sumatriptan can alleviate headaches due to carotid artery dissection. Headache, 41(6), 590-591.

Leone, M., D'Amico, D., & Frediani, F. (2000). Verapamil in the prophylaxis of episodic cluster headache: a double-blind study versus placebo. Neurology, 54(6), 1382-1385.

Leone, M., D, D. A., Moschiano, F., Fraschini, F., & Bussone, G. (1996). Melatonin versus placebo in the prophylaxis of cluster headache: a double-blind pilot study with parallel groups. Cephalalgia, 16(7), 494-496.

Leroux, E., Valade, D. F. T. I., & Taifas, I. F. V. E. (2011). Suboccipital steroid injections for transitional treatment of patients with more than two cluster headache attacks per day: a randomised, double-blind, placebo-controlled trial. Lancet Neurology, 10(10), 891-897. https://doi.org/10.1016/S1474-4422(11)70186-7

Limmroth, V., Biondi, D., Pfeil, J., & Schwalen, S. (2007). Topiramate in patients with episodic migraine: reducing the risk for chronic forms of headache. Headache, 47(1), 13-21.

Limmroth, V., Katsarava, Z., Fritsche, G., Przywara, S., & Diener, H. C. (2002). Features of medication overuse headache following overuse of different acute headache drugs. Neurology, 59(7), 1011-1014. https://doi.org/10.1212/wnl.59.7.1011

Limmroth, V., S, K., Fritsche, G., & Diener, H. C. (1999). Headache after frequent use of new serotonin agonists zolmitriptan and naratriptan. Lancet, 353(9150), 378. https://doi.org/10.1016/S0140-6736(05)74950-3

Linde, K., Allais, G., & Brinkhaus, B. (2016a). Acupuncture for the prevention of episodic migraine. Cochrane Database Syst Rev.

Linde, K., Allais, G., & Brinkhaus, B. (2016b). Acupuncture for the prevention of tension-type headache. Cochrane Database Syst Rev.

Linde, K., Allais, G., Brinkhaus, B., Manheimer, E., Vickers, A., & White, A. R. (2009). Acupuncture for tension- type headache. Cochrane Database Syst Rev.

Linde, K., & Rossnagel, K. (2004). Propranolol for migraine prophylaxis. Cochrane Database Syst Rev.

Linde, M., Mulleners, W. M., Chronicle, E. P., & McCrory, D. C. (2013a). Topiramate for the prophylaxis of episodic migraine in adults. Cochrane Database Syst Rev.

Linde, M., Mulleners, W. M., Chronicle, E. P., & McCrory, D. C. (2013b). Valproate (valproic acid or sodium valproate or a combination of the two) for the prophylaxis of episodic migraine in adults. Cochrane Database Syst Rev.

Linn, F. H., Rinkel, G. J., Algra, A., & van Gijn, J. (1998). Headache characteristics in subarachnoid haemorrhage and benign thunderclap headache. J Neurol Neurosurg Psychiatry, 65(5), 791-793. https://doi.org/10.1136/jnnp.65.5.791

Linn, F. H., Wijdicks, E. F., van der Graaf, Y., Weerdesteyn-van Vliet, F. A., Bartelds, A. I., & van Gijn, J. (1994). Prospective study of sentinel headache in aneurysmal subarachnoid haemorrhage. Lancet, 344(8922), 590-593.

Lipton, R. B., Cady, R. K., Stewart, W. F., Wilks, P., & Hall, C. (2002). Diagnostic lessons from the Spectrum Study. Neurology, 58, S27-31. https://doi.org/10.1212/wnl.58.9_suppl_6.s27

Lipton, R. B., Croop, R., Stock, E. G., Stock, D. A., Morris, B. A., Frost, M., Dubowchik, G. M., Conway, C. M., Coric, V., & Goadsby, P. J. (2019). Rimegepant, an Oral Calcitonin Gene-Related Peptide Receptor Antagonist, for Migraine. N Engl J Med, 381(2), 142-149. https://doi.org/10.1056/NEJMoa1811090

Lipton, R. B., Dodick, D., & Sadovsky, R. (2003). A self- administered screener for migraine in primary care: The ID Migraine validation study. Neurology, 61(3), 375-382.

Lipton, R. B., Dodick, D. W., & Silberstein, S. D. (2010). Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomised, double-blind, parallel-group, sham- controlled trial. Lancet Neurol, 9(4), 373-380.

Lipton, R. B., Goadsby, P. J., Sawyer, J. P., Blakeborough, P., & Stewart, W. F. (2000). Migraine: Diagnosis and assessment of disability. Reviews in Contemporary Pharmacotherapy, 11(2), 63-73.

Lipton, R. B., Goadsby, P. J., Smith, J., Schaeffler, B. A., Biondi, D. M., Hirman, J., Pederson, S., Allan, B., & Cady, R. (2020). Efficacy and safety of eptinezumab in patients with chronic migraine: PROMISE-2. Neurology, 94(13), e1365-e1377. https://doi.org/10.1212/wnl.0000000000009169

Lipton, R. B., Goldstein, J., Baggish, J. S., Yataco, A. R., Sorrentino, J. V., & Quiring, J. N. (2005). Aspirin is efficacious for the treatment of acute migraine. Headache, 45(4), 283-292.

Lipton, R. B., Mazer, C., Newman, L. C., & Solomon, S. (1997). Sumatriptan relieves migrainelike headaches associated with carbon monoxide exposure. Headache, 37(6), 392-395.

Lipton, R. B., Silberstein, S. D., & Stewart, W. F. (1994). An update on the epidemiology of migraine. Headache, 34(6), 319-328.

Locker, T. E., Thompson, C., Rylance, J., & Mason, S. M. (2006). The utility of clinical features in patients presenting with nontraumatic headache: an investigation of adult patients attending an emergency department. Headache, 46(6), 954-961.

Loder, E., Freitag, F. G., Adelman, J., Pearlmand, S., & Abu-Shakra, S. (2005). Pain-free rates with zolmitriptan 2.5 mg ODT in the acute treatment of migraine: results of a large double-blind placebo- controlled trial. Curr Med Res Opin, 21(3), 381-389. https://doi.org/10.1185/030079905x28926

Louis, P. (1981). A double-blind placebo-controlled prophylactic study of flunarizine (Sibelium) in migraine. Headache, 21(6), 235-239.

Lücking, C. H., Oestreich, W., Schmidt, R., & Soyka, D. (1988). Flunarizine vs. propranolol in the prophylaxis of migraine: two double-blind comparative studies in more than 400 patients. Cephalalgia, 8 Suppl 8, 21-26. https://doi.org/10.1177/03331024880080s805

Luda, E., Comitangelo, R., & Sicuro, L. (1995). The symptom of headache in emergency departments. The experience of a neurology emergency department. Ital J Neurol Sci, 16(5), 295-301. https://doi.org/10.1007/BF02249104

MacGregor, E. A. (2014). Migraine in pregnancy and lactation. Neurol Sci, 35, 61-64. https://doi.org/10.1007/s10072-014-1744-2

MacGregor, E. A., Chia, H., Vohrah, R. C., & Wilkinson, M. (1990). Migraine and menstruation: a pilot study. Cephalalgia, 10(6), 305-310.

MacGregor, E. A., Dowson, A., & Davies, P. T. (2002). Mouth- dispersible aspirin in the treatment of migraine: a placebo-controlled study. Headache, 42(4), 249-255.

MacGregor, E. A., Frith, A., Ellis, J., Aspinall, L., & Hackshaw, A. (2006). Prevention of menstrual attacks of migraine: a double-blind placebo-controlled crossover study. Neurology, 67(12), 2159-2163. https://doi.org/10.1212/01.wnl.0000249114.52802.55

MacGregor, E. A., Wilkinson, M., & Bancroft, K. (1993). Domperidone plus paracetamol in the treatment of migraine. Cephalalgia, 13(2), 124-127.

Mainardi, F., Maggioni, F., Pezzola, D., Zava, D., & Zanchin, G. (2014). Dexketoprofen trometamol in the acute treatment of migraine attack: a phase II, randomized, double-blind, crossover, placebo- controlled, dose optimization study. J Pain, 15(4), 388-394.

Mannix, L. K., Savani, N., & Landy, S. (2007). Efficacy and tolerability of naratriptan for short-term prevention of menstrually related migraine: data from two randomized, double-blind, placebo-controlled studies. Headache, 47(7), 1037-1049.

Manzoni, G. C. (1999). Cluster headache and lifestyle: remarks on a population of 374 male patients. Cephalalgia, 19(2), 88-94. https://doi.org/10.1046/j.1468-2982.1999.019002088.x

Manzoni, G. C., Taga, A., Russo, M., & Torelli, P. (2016). Age of onset of episodic and chronic cluster headache - a review of a large case series from a single headache centre. The Journal of Headache and Pain, 17, 44. https://doi.org/10.1186/s10194-016-0626-9

Marchenko, A., Etwel, F., Olutunfese, O., Nickel, C., Koren, G., & Nulman, I. (2015). Pregnancy outcome following prenatal exposure to triptan medications: a meta- analysis. Headache, 55(4), 490-501.

Mark, D. G., Hung, Y. Y., & Offerman, S. R. (2013). Nontraumatic subarachnoid hemorrhage in the setting of negative cranial computed tomography results: external validation of a clinical and imaging prediction rule. Ann Emerg Med, 62(1), 1-10.

Marmura, M. J., Pello Sj Fau - Young, W. B., & Young, W. B. (2010). Interictal pain in cluster headache. Cephalalgia, 30(12), 1531-1534.

Marmura, M. J., Silberstein, S. D., & Schwedt, T. J. (2015). The acute treatment of migraine in adults: the american headache society evidence assessment of migraine pharmacotherapies. Headache, 55(1), 3-20.

Matharu, M. S., Cohen, A. S., McGonigle, D. J., Ward, N., Frackowiak, R. S., & Goadsby, P. J. (2004). Posterior hypothalamic and brainstem activation in hemicrania continua. Headache, 44(8), 747-761. https://doi.org/10.1111/j.1526-4610.2004.04141.x

Matharu, M. S., Levy, M., Meeran, K., & Goadbsy, P. J. (2004). Subcutaneous ocreotide in cluster headache: Randomised placebo-controlled double-blind crossover study. Annals of Neurology, 56(4), 488-494. https://doi.org/10.1002/ana.20210

Mathew, N. T., Kurman, R., & Perez, F. (1990). Drug induced refractory headache--clinical features and management. Headache, 30(10), 634-638. https://doi.org/10.1111/j.1526-4610.1990.hed3010634.x

McNeely, W., & Goa, K. L. (1999). Diclofenac-potassium in migraine: a review. Drugs, 57(6), 991-1003.

Mehlisch, D. R., Weaver, M., & Fladung, B. (1998). Ketoprofen, acetaminophen, and placebo in the treatment of tension headache. Headache, 38(8), 579-589. https://doi.org/10.1046/j.1526-4610.1998.3808579.x

Melchart, D., Linde, K., & Streng, A. (2003). Acupuncture Randomized Trials (ART) in patients with migraine or tension-type headache--design and protocols. Forsch Komplementarmed Klass Naturheilkd, 10(4), 179-184.

Melchart, D., Streng, A., & Hoppe, A. (2005). Acupuncture in patients with tension-type headache: randomised controlled trial. Bmj, 331(7513), 376-382.

Merikangas, K. R., Angst, J., & Isler, H. (1990). Migraine and psychopathology : Results of the Zurich cohort study of young adults. Archives of General Psychiatry, 47(9), 849-853. https://doi.org/10.1001/archpsyc.1990.01810210057008

Mett, A., & Tfelt-Hansen, P. (2008). Acute migraine therapy: recent evidence from randomized comparative trials. Curr Opin Neurol, 21(3), 331-337.

Miller, D. S., Talbot, C. A., Simpson, W., & Korey, A. (1987). A comparison of naproxen sodium, acetaminophen and placebo in the treatment of muscle contraction headache. Headache, 27(7), 392-396.

Mitsikostas, D. D., & Polychronidis, I. (1997). Valproate versus flunarizine in migraine prophylaxis: a randomized, double-open, clinical trial. Funct Neurol, 12(5), 267-276.

Moja, P. L., Cusi, C., Sterzi, R. R., & Canepari, C. (2005). Selective serotonin re-uptake inhibitors (SSRIs) for preventing migraine and tension-type headaches. Cochrane Database Syst Rev.

Mokri, B. (1999). Spontaneous cerebrospinal fluid leaks: from intracranial hypotension to cerebrospinal fluid hypovolemia--evolution of a concept. Mayo Clin Proc, 74(11), 1113-1123.

Momoh-Ojewuyi, A., Ayubi, A., & Abusamra, R. (2013). Side-locked headaches. The Journal of Headache and Pain, 14, p64. https://doi.org/10.1186/1129-2377-14-S1-P64

Morgan, C. J., Pyne-Geithman, G. J., & Jauch, E. C. (2004). Bilirubin as a cerebrospinal fluid marker of sentinel subarachnoid hemorrhage: a preliminary report in pigs. J Neurosurg, 101(6), 1026-1029. https://doi.org/10.3171/jns.2004.101.6.1026

Morgenstern, L. B., Luna-Gonzales, H., & Huber, J. C. (1998). Worst headache and subarachnoid hemorrhage: prospective, modern computed tomography and spinal fluid analysis. Ann Emerg Med, 32, 297-304.

Morris, Z., Whiteley, W. N., Longstreth, W. T., Jr., Weber, F., Lee, Y. C., Tsushima, Y., Alphs, H., Ladd, S. C., Warlow, C., Wardlaw, J. M., & Al-Shahi Salman, R. (2009). Incidental findings on brain magnetic resonance imaging: systematic review and meta-analysis. Bmj, 339, b3016. https://doi.org/10.1136/bmj.b3016

Myllyl, V. V., Havanka, H., & Herrala, L. (1998). Tolfenamic acid rapid release versus sumatriptan in the acute treatment of migraine: comparable effect in a double-blind, randomized, controlled, parallel-group study. Headache, 38(3), 201-207. https://doi.org/10.1046/j.1526-4610.1998.3803201.x

Natoli, J. L., Manack, A., & Dean, B. (2010). Global prevalence of chronic migraine: a systematic review. Cephalalgia, 30(5), 599-609.

Newman, H. C., Lipton, R. B., & Solomon, S. (1994). Hemicrania continua: ten new cases and a review of the literature. Neurology, 44(11), 2111-2114.

Newman, L., Mannix, L. K., & Landy, S. (2001). Naratriptan as short-term prophylaxis of menstrually associated migraine: a randomized, double-blind, placebo-controlled study. Headache, 41(3), 248-256.

Nezvalov -Henriksen, K., Spigset, O., & Nordeng, H. (2013). Triptan safety during pregnancy: a Norwegian population registry study. Eur J Epidemiol, 28(9), 759-769.

NICE. (2012). Nice Technology Appraisal guidance 260 Botulinum Toxin Type A in the prevention of headache in adults with Chronic Migraine.

Nierenburg, H., & Stark-Inbar, A. (2022). Nerivio(®) remote electrical neuromodulation for acute treatment of chronic migraine. Pain Manag, 12(3), 267-281. https://doi.org/10.2217/pmt-2021-0038

Obermann, M., Yoon, M. S., & Dommes, P. (2007). Prevalence of trigeminal autonomic symptoms in migraine: a population-based study. Cephalalgia, 27(6), 504-509.

Olerud, B., Gustavsson, C. L., & Furberg, B. (1986). Nadolol and propranolol in migraine management. Headache, 26(10), 490-493.

Olesen, J. (1978). Some clinical features of the acute migraine attack. An analysis of 750 patients. Headache, 18(5), 268-271. https://doi.org/10.1111/j.1526-4610.1978.hed1805268.x

Olesen, J. (2012). Detoxification for medication overuse headache is the primary task. Cephalalgia, 32(5), 420-422.

Olesen, J., Diener, H. C., Schoenen, J., & Hettiarachchi, J. (2004). No effect of eletriptan administration during the aura phase of migraine. European Journal of Neurology, 11(10), 671-677.

Olsson, J. E., Behring, H. C., & Forssman, B. (1984). Metoprolol and propranolol in migraine prophylaxis: a double-blind multicentre study. Acta Neurol Scand, 70(3), 160-168.

Ontario, H. Q. (2010). Neuroimaging for the evaluation of chronic headaches: an evidence-based analysis. Ont Health Technol Assess Ser, 10(26), 1-57.

Paemeleire, K., Bahra, A., Evers, S., Matharu, M. S., & Goadbsy, P. J. (2006). Medication-overuse headache in patients with cluster headache. Neurology, 67(1), 109-113.

Pageler, L., Katsarava, Z., Limmroth, V., & Diener, H. C. (2004). Prednisolone in the treatment of medication withdrawal headache following medication overuse headache: a placebo-controlled, double- blind and randomised pilot study. Cephalalgia, 33(3), 202-207. https://doi.org/10.1177/0333102412462638

Pareja, J. A. (1995). Hemicrania continua: remitting stage evolved from the chronic form. Headache, 35(3), 161-162.

Pareja, J. A., Caminero, A., Franco, E., Casado, J. L., Pascual, J., & Sanchez del Rio, M. (2001). Dose, efficacy and tolerability of long-term indomethacin treatment of chronic paroxysmal hemicrania and hemicrania continua. Cephalalgia, 21(9), 906-910.

Pareja, J. A., Kruszewski, P., & Sjaastad, O. (1995). SUNCT syndrome: trials of drugs and anaesthetic blockades. Headache, 35(3), 138-142.

Pascual, J., Falk, R. M., & Piessens, F. (2000). Consistent efficacy and tolerability of almotriptan in the acute treatment of multiple migraine attacks: results of a large, randomized, double-blind, placebo- controlled study. Cephalalgia, 20(6), 588-596. https://doi.org/10.1046/j.1468-2982.2000.00091.x

Peres, M. F., Stiles, M., Oshinsky, M., & Rozen, T. D. (2001). Remitting form of hemicrania continua with seasonal pattern. Headache, 41(6), 592-594. https://doi.org/10.1046/j.1526-4610.2001.041006592.x

Peres, M. F. P., Silberstein, S. D., & Nahmias, S. (2001). Hemicrania continua is not that rare. Neurolgy, 57(6), 948-951. https://doi.org/10.1212/wnl.57.6.948

Perry, J. J., Spacek, A., & Forbes, M. (2008). Is the combination of negative computed tomography result and negative lumbar puncture result sufficient to rule out subarachnoid hemorrhage? . Ann Emerg Med, 51(6), 707-713.

Perry, J. J., Stiell, I. G., & Sivilotti, M. L. (2011). Sensitivity of computed tomography performed within six hours of onset of headache for diagnosis of subarachnoid haemorrhage: prospective cohort study. Bmj, 18(343), d4277.

https://doi.org/10.1136/bmj.d4277

Peters, G. A., & Horton, B. T. (1951). Headache: With special reference to the excessive use of ergotamine preparations and withdrawal effects. Proceedings of the Staff Meetings of the Mayo Clinic, 26(9), 153-161.

Pfadenhauer, K., Sch nsteiner, T., & Keller, H. (2006). The risks of sumatriptan administration in patients with unrecognized subarachnoid haemorrhage (SAH). Cephalalgia, 26(3), 320-323.

Pfaffenrath, V., Diener, H. C., & Isler, H. (1994). Efficacy and tolerability of amitriptylinoxide in the treatment of chronic tension-type headache: a multi-centre controlled study. Cephalalgia, 14(2), 149-155.

Physicians. (2002). Clinical policy: critical issues in the evaluation and management of patients presenting to the emergency department with acute headache. Ann Emerg Med, 39(1), 108-122.

Pini, L. A., Del Bene, E., & Zanchin, G. (2008). Tolerability and efficacy of a combination of paracetamol and caffeine in the treatment of tension-type headache: a randomised, double-blind, double- dummy, cross-over study versus placebo and naproxen sodium. J Headache Pain, 9(6), 367-373.

Poolsup, N., Leelasangaluk, V., Jittangtrong, J., Rithlamlert, C., Ratanapantamanee, N., & Khanthong, M. (2005). Efficacy and tolerability of frovatriptan in acute migraine treatment: systematic review of randomized controlled trials. J Clin Pharm Ther, 30(6), 521-532.

Pozo-Rosich, P., Ailani, J., Ashina, M., Goadsby, P. J., Lipton, R. B., Reuter, U., Guo, H., Schwefel, B., Lu, K., Boinpally, R., Miceli, R., De Abreu Ferreira, R., McCusker, E., Yu, S. Y., Severt, L., Finnegan, M., & Trugman, J. M. (2023). Atogepant for the preventive treatment of chronic migraine (PROGRESS): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet, 402(10404), 775-785. https://doi.org/10.1016/s0140-6736(23)01049-8

Pradalier, A., Serratrice, G., & Collard, M. (1989). Long- acting propranolol in migraine prophylaxis: results of a double-blind, placebo-controlled study. Cephalalgia, 9(4), 247-253.

Pradalier, A., Vincent, D., Beaulieu, P., Baudesson, G., & Launay, J. (1994). Correlation between oestradiol plasma level and therapeutic effect on menstrual migraine. In.

Prakash, S., Belani, P. F. S. A., Susvirkar, A. F. T. A., Trivedi, A. F. A. S., Ahuja, S. F. P. A., & Patel, A. (2013). Paroxysmal hemicrania: a retrospective study of a consecutive series of 22 patients and a critical analysis of the diagnostic criteria. The Journal of Headache and Pain, 1414(26), 1-8.

Prakash, S., & Golwala, P. (2012). A proposal for revision of hemicrania continua diagnostic criteria based on critical analysis of 62 patients. Cephalalgia, 32(11), 860-868.

Prakash, S., & Patell, R. (2014). Paroxysmal hemicrania: an update. Current Pain and Headache Reports, 18(4), 407. https://doi.org/10.1007/s11916-014-0407-6

Prior, M. J., Cooper, K. M., May, L. G., & Bowen, D. L. (2002). Efficacy and safety of acetaminophen and naproxen in the treatment of tension-type headache. A randomized, double-blind, placebo- controlled trial. Cephalalgia, 22(9), 740-748. https://doi.org/10.1046/j.1468-2982.2002.00419.x

Rabbie, R., Derry, S., & Moore, R. A. (2013). Ibuprofen with or without an antiemetic for acute migraine headaches in adults. Cochrane Database Syst Rev.

Rabe, K., Pageler, L., & Gaul, C. (2013). Prednisone for the treatment of withdrawal headache in patients with medication overuse headache: a randomized, double-blind, placebo-controlled study. Cephalalgia, 33(3), 202-207.

Radat, F., & Lanteri-Minet, M. (2010). What is the role of dependence-related behavior in medication- overuse headache? . Headache, 50(10), 1597- 1611.

Ramirez-Lassepas, M., Espinosa, C. E., Cicero, J. J., Johnston, K. L., Cipolle, R. J., & Barber, D. L. (1997). Predictors of intracranial pathologic findings in patients who seek emergency care because of headache. Arch Neurol, 54(12), 1506-1509.

Ramon, C., Mauri, G. F. V. J., Vega, J. F. R. M., Rico, M. F. P. M., Para, M. F. P. J., & Pascual, J. (2013). Diagnostic distribution of 100 unilateral, side-locked headaches consulting a specialized clinic. European Neurology, 69(5), 289-291.

Rapoport, A. M., Mathew Nt Fau - Silberstein, S. D., & Silberstein Sd Fau - Dodick, D. (2007). Zolmitriptan nasal spray in the acute treatment of cluster headache: a double-blind study. Neurology, 69(9), 821-826.

Rasmussen, B. K., Jensen, R., & Olesen, J. (1991). A population-based analysis of the diagnostic criteria of the International Headache Society. Cephalalgia, 11(3), 129-134.

Rasmussen, B. K., Jensen, R., Schroll, M., & Olesen, J. (1992). Interrelations between migraine and tension-type headache in the general population. Arch Neurol, 49(9), 914-918.

Rasmussen, B. K., & Olesen, J. (1992). Migraine with and without aura: an epidemiological study. Cephalagia, 12(4), 221-228.

Reuter, U., Goadsby, P. J., & Lanteri-Minet, M. (2018). Efficacy and tolerability of erenumab in patients with episodic migraine in whom two-to-four previous preventive treatments were unsuccessful: a randomised, double-blind, placebo-controlled, phase 3b study. Lancet, 392(10161), 2280-2287.

Rizzoli, P., Marmura, M. J., Robblee, J., McVige, J., Sacco, S., Nahas, S. J., Ailani, J., De Abreu Ferreira, R., Ma, J., Smith, J. H., Dabruzzo, B., & Ashina, M. (2024). Safety and tolerability of atogepant for the preventive treatment of migraine: a post hoc analysis of pooled data from four clinical trials. J Headache Pain, 25(1), 35. https://doi.org/10.1186/s10194-024-01736-z

Robbins, L. (1995). Intranasal lidocaine for cluster headache. Headache.

Robbins, M. S., Grosberg Bm Fau - Lipton, R. B., & Lipton, R. B. (2010). Coexisting trigeminal autonomic cephalalgias and hemicrania continua. Headache, 50(3), 489-496.

Ross-Lee, L. M., Eadie, M. J., Heazlewood, V., Bochner, F., & Tyrer, J. H. (1983). Aspirin pharmacokinetics in migraine. The effect of metoclopramide. Eur J Clin Pharmacol, 24(6), 777-785. https://doi.org/10.1007/bf00607087

Rossi, P., Di Lorenzo, C., Faroni, J., Cesarino, F., & Nappi, G. (2006). Advice alone vs. structured detoxification programmes for medication overuse headache: a prospective, randomized, open-label trial in transformed migraine patients with low medical needs. Cephalalgia, 26(9), 1097-1105. https://doi.org/10.1111/j.1468-2982.2006.01175.x

Rossi, P., Faroni, J. V., & Nappi, G. (2008). Medication overuse headache: predictors and rates of relapse in migraine patients with low medical needs. A 1-year prospective study. Cephalagia, 28(11), 1196-1200. https://doi.org/10.1111/j.1468-2982.2008.01659.x

Rossi, P., Faroni, J. V., & Nappi, G. (2011). Short-term effectiveness of simple advice as a withdrawal strategy in simple and complicated medication overuse headache. Eur J Neurol, 18(3), 396-401. https://doi.org/10.1111/j.1468-1331.2010.03157.x

Rossi, P., Jensen, R., Nappi, G., Allena, M., & Consortium, C. (2009). A narrative review on the management of medication overuse headache: the steep road from experience to evidence. J Headache Pain, 10(6), 407-417.

Rothrock, J. (2005). The perils of misinterpreting a treatment response. Headache, 45(5), 599-600. https://doi.org/10.1111/j.1526-4610.2005.05115.x

Rothrock, J. F., Parada, V. A., Sims, C., Key, K., Walters, N. S., & Zweifler, R. M. (2006). The impact of intensive patient education on clinical outcome in a clinic-based migraine population. Headache, 46(5), 726-731. https://doi.org/10.1111/j.1526-4610.2006.00428.x

Rowsell, A. R., Neylan, C., & Wilkinson, M. (1973). Ergotamine induced headaches in migrainous patients. Headache, 13(2), 65-67. https://doi.org/10.1111/j.1526-4610.1973.hed1302065.x

Rozen, T. D., & Fishman, R. S. (2012). Cluster headache in the United States of America: demographics, clinical characteristics, triggers, suicidality, and personal burden. Headache, 52(1), 99-113.

Russell, D. (1981). Cluster headache: severity and temporal profiles of attacks and patient activity prior to and during attacks. Cephalalgia, 1(4), 209-216. https://doi.org/10.1046/j.1468-2982.1981.0104209.x

Russell, M. B., Rasmussen, B. K., Fenger, K., & Olesen, J. (1996). Migraine without aura and migraine with aura are distinct clinical entities: a study of four hundred and eighty-four male and female migraineurs from the general population. Cephalalgia, 16(4), 239-245. https://doi.org/10.1046/j.1468-2982.1996.1604239.x

Russell, M. B., Rasmussen, B. K., Thorvaldsen, P., & Olesen, J. (1995). Prevalence and sex-ratio of the subtypes of migraine. International Journal of Epidemiology, 24(3), 612-618.

Sances, G., Granella, F., & Nappi, R. E. (2003). Course of migraine during pregnancy and postpartum: a prospective study. Cephalalgia, 23(3), 197-205. https://doi.org/10.1046/j.1468-2982.2003.00480.x

Sándor, P. S., Di Clemente, L., Coppola, G., Saenger, U., Fumal, A., Magis, D., Seidel, L., Agosti, R. M., & Schoenen, J. (2005). Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial. Neurology, 64(4), 713-715. https://doi.org/10.1212/01.Wnl.0000151975.03598.Ed

Saper, J. R. (1987). Ergotamine dependancy - a review. Headache, 27(8), 435-438.

Sargent, J. D., Baumel, B., & Peters, K. (1988). Aborting a migraine attack: naproxen sodium v ergotamine plus caffeine. Headache, 28(4), 263-266.

Scher, A. I., Stewart, W. F., Lieberman, J., & Lipton, R. B. (1997). Prevalence of frequent headache in a population sample. Headache, 38(7), 497-506. https://doi.org/10.1046/j.1526-4610.1998.3807497.x

Schievink, W. I. (2006). Spontaneous spinal cerebrospinal fluid leaks and intracranial hypotension. JAMA, 295(19), 2286-2296.

Schievink, W. I., Wijdicks, E. F., Meyer, F. B., & Sonntag, V. K. (2001). Spontaneous intracranial hypotension mimicking aneurysmal subarachnoid hemorrhage. Neurosurgery, 48(3), 516-517.

Schoenen, J., Jacquy, J., & Lenaerts, M. (1998). Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial. Neurology, 50(2), 466-470. https://doi.org/10.1212/wnl.50.2.466

Schoenen, J., Jensen, R. H., & Lanteri-Minet, M. (2013). Stimulation of the sphenopalatine ganglion (SPG) for cluster headache treatment. Pathway CH-1: a randomized, sham-controlled study. Cephalagia, 33(10), 816-830.

Schoenen, J., Vandersmissen, B., & Jeangette, S. (2013). Migraine prevention with a supraorbital transcutaneous stimulator: a randomized controlled trial. Neurology, 80(8), 697-704.

Schrader, H., Stovner, L. J., Helde, G., Sand, T., & Bovim, G. (2001). Prophylactic treatment of migraine with angiotensin converting enzyme inhibitor (lisinopril): randomised, placebo controlled, crossover study. Bmj, 322(7277), 19-22.

Schurks, M., Kurth, T., de Jesus, J., Jonjic, M., Rosskopf, D., & Diener, H. C. (2006). Cluster headache: clinical presentation, lifestyle features, and medical treatment. Headache.

Selby, G., & Lance, J. W. (1960). Observations on 500 cases of migraine and allied vascular headache. J Neurol Neurosurg Psychiat, 23(23), 23-32.

Sempere, A. P., Porta-Etessam, J., & Medrano, V. (2005). Neuroimaging in the evaluation of patients with non-acute headache. Cephalalgia, 25(1), 30-35. https://doi.org/10.1111/j.1468-2982.2004.00798.x

Seymour, J. J., Moscati, R. M., & Jehle, D. V. (1995). Response of headaches to nonnarcotic analgesics resulting in missed intracranial hemorrhage. Am J Emerg Med, 13(1), 43-45.

Sharma, S., Prasad, A., & Nehru, R. (2002). Efficacy and tolerability of prochlorperazine buccal tablets in treatment of acute migraine. Headache, 42(9), 896-902.

Shibata, T., Kubo, M., Kuwayama, N., Hirashima, Y., & Endo, S. (2006). Warning headache of subarachnoid hemorrhage and infarction due to vertebrobasilar artery dissection. Clin J Pain, 22(2), 193-196. https://doi.org/10.1097/01.ajp.0000176419.15381.2d

Silberstein, S. D., Calhoun, A. H., & Lipton, R. B. (2016). Chronic migraine headache prevention with noninvasive vagus nerve stimulation: The EVENT study. Neurology, 87(5), 529-538.

Silberstein, S. D., Dodick, D. W., & Bigal, M. E. (2017). Fremanezumab for the Preventive Treatment of Chronic Migraine. N Engl J Med, 377(22), 2113-2122.

Silberstein, S. D., Elkind, A. H., Schreiber, C., & Keywood, C. (2004). A randomized trial of frovatriptan for the intermittent prevention of menstrual migraine. Neurology, 63(2), 261-269.

Silberstein, S. D., Lipton, R. B., & Dodick, D. W. (2007). Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial. Headache, 47(2), 170-180.

Silberstein, S. D., Neto, W., Schmitt, J., Jacobs, D., & Group, M. S. (2004). Topiramate in migraine prevention: results of a large controlled trial. Arch Neurol, 61(4), 490-495.

Silverman, K., Evans, S. M., Strain, E. C., & Griffiths, R. R. (1992). Withdrawal syndrome after the double-blind cessation of caffeine consumption. N Engl J Med, 327(16), 1109-1114. https://doi.org/10.1056/nejm199210153271601

Silvestrini, M., Bartolini, M., Coccia, M., Baruffaldi, R., Taffi, R., & Provinciali, L. (2003). Topiramate in the treatment of chronic migraine. Cephalalgia, 23(8), 820-824. https://doi.org/10.1046/j.1468-2982.2003.00592.x

Sjaastad, O. (1992). Cluster headache syndrome. London: W.

Sjaastad, O., & Bakketeig, L. S. (2003). Cluster headache prevalence. Vågå study of headache epidemiology. Cephalalgia, 23(7), 528-533. https://doi.org/10.1046/j.1468-2982.2003.00585.x

Sjaastad, O., & Bakketeig, L. S. (2007). The rare, unilateral headaches. Vaga study of headache epidemiology, 8(1), 19-27.

Sjaastad, O., Saunte, C., & Fredriksen, T. A. (1985). Bilaterality of cluster headache. Cephalalgia.

Sjaastad, O., Saunte, C., & Salveson, R. (1989). Shortlasting unilateral neuralgiform headache attacks with conjunctival injection, tearing, sweating and rhinorhea. Cephalalgia.

Skljarevski, V., Matharu, M., Millen, B. A., Ossipov, M. H., Kim, B. K., & Yang, J. Y. (2018). Efficacy and safety of galcanezumab for the prevention of episodic migraine: Results of the EVOLVE-2 Phase 3 randomized controlled clinical trial. Cephalalgia, 38(8), 1442-1454.

Spielmann, K., Kayser, A., Beck, E., Meister, R., & Schaefer, C. (2018). Pregnancy outcome after anti- migraine triptan use: A prospective observational cohort study. Cephalalgia, 38(6), 1081-1092.

Spierings, E. L., Rapoport, A. M., Dodick, D. W., & Charlesworth, B. (2004). Acute treatment of migraine with zolmitriptan 5 mg orally disintegrating tablet. CNS Drugs, 18(15), 1133-1141.

Stauffer, V. L., Dodick, D. W., Zhang, Q., Carter, J. N., Ailani, J., & Conley, R. R. (2018). Evaluation of Galcanezumab for the Prevention of Episodic Migraine: The EVOLVE-1 Randomized Clinical Trial. JAMA Neurol, 75(9), 1080-1088.

Steiner, T. J., Husøy, A., & Stovner, L. J. (2024). GBD2021: headache disorders and global lost health - a focus on children, and a view forward. J Headache Pain, 25(1), 91. https://doi.org/10.1186/s10194-024-01795-2

Steiner, T. J., Joseph, R., Hedman, C., & Rose, F. C. (1988). Metoprolol in the prophylaxis of migraine: parallel group comparison with placebo and dose ranging followup. Headache, 28(1), 15-23. https://doi.org/10.1111/j.1365-2524.1988.hed2801015.x

Steiner, T. J., & Lange, R. (1998). Ketoprofen (25 mg) in the symptomatic treatment of episodic tension-type headache: double-blind placebo-controlled comparison with acetaminophen (1000 mg). Cephalalgia, 18(1), 38-43.

Steiner, T. J., Scher, A. I., Stewart, W. F., Kolodner, K., Liberman, J., & Lipton, R. B. (2003). The prevalence and disability burden of adult migraine in England and their relationship to age, gender and ethnicity. Cephalalgia, 23(7), 519-527.

Stephens, G., Derry, S., & Moore, R. A. (2016). Paracetamol (acetaminophen) for acute treatment of episodic tension-type headache in adults. Cochrane Database Syst Rev.

Stewart, H., Reuben, A., & McDonald, J. (2014). LP or not LP, that is the question: gold standard or unnecessary procedure in subarachnoid haemorrhage? . Emerg Med J, 31(9), 720-723.

Stewart, W. F., Lipton, R. B., Chee, E., Sawyer, J., & Silberstein, S. D. (2000). Menstrual cycle and headache in a population sample of migraineurs. Neurology, 55(10), 1517-1523.

Stewart, W. F., Schecter, A., & Lipton, R. B. (1994). Migraine heterogeneity: disability, pain intensity, and attack frequency and duration. Neurology, 44, S24-39.

Stewart, W. F., Shechter, A., & Rasmussen, B. K. (1994). Migraine prevalence. A review of population-based studies. Neurology, 44(6 Suppl 4), S17-23.

Storey, J. R., Calder, C. S., Hart, D. E., & Potter, D. L. (2001). Topiramate in migraine prevention: a double- blind, placebo-controlled study. Headache, 41(10), 968-975.

Stovner, L., Hagen, K., & Jensen, R. (2007). The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia, 27(3), 193-210.

Stovner, L. J., Linde, M., & Gravdahl, G. B. (2014). A comparative study of candesartan versus propranolol for migraine prophylaxis: A randomised, triple-blind, placebo-controlled, double cross-over study. Cephalalgia, 34(7), 523-532.

Sutherland, J. M., & Eadie, M. J. (1972). Cluster headache. Res Clin Stud Headache.

Tang-Wai, D. F., Phan, T. G., & Wijdicks, E. F. (2001). Hypertensive encephalopathy presenting with thunderclap headache. Headache, 41(2), 198-200.

Tassorelli, C., Jensen, R., & Allena, M. (2014). A consensus protocol for the management of medication-overuse headache: Evaluation in a multicentric, multinational study. Cephalalgia, 34(9), 645-655.

Tassorelli, C., Nagy, K., Pozo-Rosich, P., Lanteri-Minet, M., Sacco, S., Nežádal, T., Guo, H., De Abreu Ferreira, R., Forero, G., & Trugman, J. M. (2024). Safety and efficacy of atogepant for the preventive treatment of episodic migraine in adults for whom conventional oral preventive treatments have failed (ELEVATE): a randomised, placebo-controlled, phase 3b trial. Lancet Neurol, 23(4), 382-392. https://doi.org/10.1016/s1474-4422(24)00025-5

Tavola, T., Gala, C., Conte, G., & Invernizzi, G. (1992). Traditional Chinese acupuncture in tension-type headache: a controlled study. Pain, 48(3), 325-329.

Tepper, S., Ashina, M., & Reuter, U. (2017). Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial. Lancet Neurol, 16(6), 425-434.

Tepper, S. J., Dahl f, C. G., & Dowson, A. (2004). Prevalence and diagnosis of migraine in patients consulting their physician with a complaint of headache: data from the Landmark Study. Headache, 44(9), 856-864.

Tepper, S. J., Rabany, L., Cowan, R. P., Smith, T. R., Grosberg, B. M., Torphy, B. D., Harris, D., Vizel, M., Ironi, A., Stark-Inbar, A., & Blumenfeld, A. M. (2023). Remote electrical neuromodulation for migraine prevention: A double-blind, randomized, placebo-controlled clinical trial. Headache, 63(3), 377-389. https://doi.org/10.1111/head.14469

Terlizzi, R., Cevoli, S., Nicodemo, M., Pierangeli, G., Grimaldi, D., & Cortelli, P. (2011). A case of strictly unilateral migraine without aura transformed in an episodic hemicrania continua. Neurol Sci, 32(1), 169-170. https://doi.org/10.1007/s10072-010-0418-y

Tfelt-Hansen, P., & Olesen, J. (1984). Effervescent metoclopramide and aspirin (Migravess) versus effervescent aspirin or placebo for migraine attacks: a double-blind study. Cephalalgia, 4(2), 107-111.

Tfelt-Hansen, P., Standnes, B., Kangasneimi, P., Hakkarainen, H., & Olesen, J. (1984). Timolol vs propranolol vs placebo in common migraine prophylaxis: a double-blind multicenter trial. Acta Neurol Scand, 69(1), 1-8.

Tiwari, A., Maurya, P. K., Qavi, A., Kulshreshtha, D., Thacker, A. K., & Singh, A. K. (2022). Cranial Autonomic Symptoms in Migraine: An Observational Study. Ann Indian Acad Neurol, 25(4), 654-659. https://doi.org/10.4103/aian.aian_948_21

Tokola, R. A. (1988). The effect of metoclopramide and prochlorperazine on the absorption of effervescent paracetamol in migraine. Cephalalgia, 8(3), 139-147.

Tokola, R. A., Kangasniemi, P., Neuvonen, P. J., & Tokola, O. (1983). Tolfenamic acid, metoclopramide, caffeine and their combinations in the treatment of migraine attacks. Cephalalgia, 4(4), 253-263.

Torelli, P., Cologno, D., Cademartiri, C., & Manzoni, G. C. (2001). Application of the International headache classification criteria in 652 cluster headache patients. Cephalagia, 21(2), 145-150.

Totzeck, A., Diener Hc Fau - Gaul, C., & Gaul, C. (2014). Concomitant occurrence of different trigeminal autonomic cephalalgias: a case series and review of the literature. Cephalalgia, 34(3), 231-235. https://doi.org/10.1177/0333102413506127

Tronvik, E., Stovner, L. J., Helde, G., Sand, T., & Bovim, G. (2003). Prophylactic treatment of migraine with an angiotensin II receptor blocker: a randomized controlled trial. JAMA, 289(1), 65-69.

Tsushima, Y., & Endo, K. (2005). MR Imaging in the Evaluation of Chronic or Recurrent Headache. Radiology, 235(2), 575-579.

Tuchman, M. M., Hee, A., Emeribe, U., & Silberstein, S. (2008). Oral zolmitriptan in the short-term prevention of menstrual migraine: a randomized, placebo- controlled study. CNS Drugs, 22(10), 877-886. https://doi.org/10.2165/00023210-200822100-00007

Ulrich, V., Russell, M. B., Jensen, R., & Olesen, J. (1996). A comparison of tension-type headache in migraineurs and in non-migraineurs: a population- based study. Pain, 67(2-3), 501-506. https://doi.org/10.1016/0304-3959(96)03164-8

Vaidhyanath, R., Kenningham, R., Khan, A., & Messios, N. (2007). Spontaneous intracranial hypotension: a cause of severe acute headache. Emerg Med J, 24(10), 739-741.

van Dusseldorp, M., & Martijn, B. K. (1990). Headache caused by caffeine withdrawal among moderate coffee drinkers switched from ordinary to decaffeinated coffee: a 12 week double-blind trial. British Medical Journal, 300(6739), 1558-1559. https://doi.org/10.1136/bmj.300.6739.1558

van Gerven, J. M., Schoemaker, R. C., & Jacobs, L. D. (1996). Self-medication of a single headache episode with ketoprofen, ibuprofen or placebo, home- monitored with an electronic patient diary. Br J Clin Pharmacol, 42(4), 475-481.

van Vliet, J. A., Eekers, J. A., Haan, J., & Ferrari, M. (2003). Features involved in the diagnostic delay of cluster headache. Jouranl of Neurology, Neurosurgery and Psychiatry, 74(8), 1123-1125. https://doi.org/10.1136/jnnp.74.8.112

van Vliet, J. A., Eekers, P. J., Haan, J., & Ferrari, M. D. (2006). Evaluating the IHS criteria for cluster headache-- a comparison between patients meeting all criteria and patients failing one criterion. Cephalalgia, 26(3), 241-245.

Vázquez-Barquero, A., Ibáñez, F. J., Herrera, S., Izquierdo, J. M., Berciano, J., & Pascual, J. (1994). Isolated headache as the presenting clinical manifestation of intracranial tumors: a prospective study. Cephalalgia, 14(4), 270-272. https://doi.org/10.1046/j.1468-2982.1994.1404270.x

Vernooij, M. W., Ikram, M. A., & Tanghe, H. L. (2007). Incidental findings on brain MRI in the general population. The New England journal of medicine, 357(18), 1821-1828.

Vetvik, K. G., MacGregor, E. A., Lundqvist, C., & Russell, M. B. (2010). Self-reported menstrual migraine in the general population. J Headache Pain, 11(2), 87-92.

Veys, L., Derry, S., & Moore, R. A. (2016). Ketoprofen for episodic tension-type headache in adults. Cochrane Database Syst Rev.

Victor, T. W., Hu, X., Campbell, J., White, R. E., Buse, D. C., & Lipton, R. B. (2010). Association between migraine, anxiety and depression. Cephalalgia, 30(5), 567-575.

Vikelis, M., & Rapoport, A. M. (2016). Cluster headache in Greece: an observational clinical and demographic study of 302 patients. J Headache Pain, 17(1), 88-97.

Vlak, M. H., Algra, A., Brandenburg, R., & Rinkel, G. J. (2011). Prevalence of unruptured intracranial aneurysms, with emphasis on sex, age, comorbidity, country, and time period: a systematic review and meta- analysis. Lancet Neurol, 10(7), 626-636.

Wainscott, G., Volans, G., & Wilkinson, M. (1974). Letter: Ergotamine- induced headache. British Medical Journal, 2(5921), 724. https://doi.org/10.1136/bmj.2.5921.724-b

Wang, Q., Wang, S., Zhu, Y., & Lin, F. (2023). Clinical efficacy and safety of rimegepant in the treatment of migraine: a meta-analysis of randomized controlled trials. Front Neurol, 14, 1205778. https://doi.org/10.3389/fneur.2023.1205778

Wang, S. J., & Fuh, J. L. (2005). Exertional but not postural headache resulting from spontaneous intracranial hypotension. Acta Neurol Taiwan, 14(1), 36-37.

Wang, S. J., Fuh, J. L., & Lu, S. R. (2000). Chronic daily headache in Chinese elderly: prevalence, risk factors and biannual follow-up. Neurology, 54(2), 314-319.

Weatherall, M. W., & Bahra, A. (2011). Familial hemicrania continua. Cephalalgia, 31(2), 245-249.

Weber, F., & Knopf, H. (2006). Incidental findings in magnetic resonance imaging of the brains of healthy young men. Journal of the Neurological Sciences, 240(1-2), 81-84. https://doi.org/10.1016/j.jns.2005.09.008

Weng, H. Y., Cohen, A. S., Schankin, C., & Goadsby, P. J. (2017). Phenotypic and treatment outcome data on SUNCT and SUNA, including a randomised placebo-controlled trial. Cephalalgia, 38(9), 1554-1563. https://doi.org/10.1177/0333102417739304

Westergaard, M. L., Hansen, E. H., Gl mer, C., Olesen, J., & Jensen, R. H. (2014). Definitions of medication-overuse headache in population-based studies and their implications on prevalence estimates: a systematic review. Cephalalgia, 34(6), 409-425. https://doi.org/10.1177/0333102413512033

White, A. R., Resch, K. L., & Chan, J. C. (2000). Acupuncture for episodic tension-type headache: a multicentre randomized controlled trial. Cephalalgia, 20(7), 632-637.

Williams, M. H., & Broadley, S. A. (2008). SUNCT and SUNA: clinical features and medical treatment. J Clin Neurosci, 15(5), 526-534.

Wöber, C., Brannath, W., Schmidt, K., Kapitan, M., Rudel, E., Wessely, P., & Wöber-Bingöl, C. (2007). Prospective analysis of factors related to migraine attacks: the PAMINA study. Cephalalgia, 27(4), 304-314. https://doi.org/10.1111/j.1468-2982.2007.01279.x

Wolfson, W. Q., & Graham, J. R. (1949). Development of tolerance to ergot alkaloids in a patient with unusually severe migraine. The New England journal of medicine, 241(8), 296-298.

Yablon, L. A., & Newman, L. C. (2010). Hemicrania continua: a second case in which the remitting form evolved from the chronic form. Headache, 50(8), 1381-1383.

Young, W. B., & Rozen, T. D. (1999). Bilateral cluster headache: case report and a theory of (failed) contralateral supression. Cephalalgia, 19(3), 188-190. https://doi.org/10.1046/j.1468-2982.1999.1903188.x

Young, W. B., & Silberstein, S. D. (1993). Hemicrania continua and symptomatic medication overuse. Headache, 33(9), 485-487.

Yu, S., & Han, X. (2015). Update of chronic tension-type headache. Curr Pain Headache Rep, 19(1), 469. https://doi.org/10.1007/s11916-014-0469-5

Zeeberg, P., Olesen, J., & Jensen, R. (2006a). Discontinuation of medication overuse in headache patients: recovery of therapeutic responsiveness. Cephalalgia, 26(10), 1192-1198.

Zeeberg, P., Olesen, J., & Jensen, R. (2006b). Probable medication-overuse headache: the effect of a 2- month drug-free period. Neurology, 66(12), 1894-1898.

Ziegler, D. K., Hurwitz, A., Hassanein, R. S., Kodanaz, H. A., Preskorn, S. H., & Mason, J. (1987). Migraine prophylaxis. A comparison of propranolol and amitriptyline. Arch Neurol, 44(5), 486-489. https://doi.org/10.1001/archneur.1987.00520170016015

Ziegler, D. K., Hurwitz, A., Preskorn, S., Hassanein, R., & Seim, J. (1993). Propranolol and amitriptyline in prophylaxis of migraine. Pharmacokinetic and therapeutic effects, 50(8), 825-830. https://doi.org/10.1001/archneur.1993.00540080036010

Zwart, J. A., Dyb, G., Hagen, K., Svebak, S., Stovner, L. J., & Holmen, J. (2004). Analgesic overuse among subjects with headache, neck, and low-back pain. Neurology, 62(9), 1540-1544.